Cargando…

Modulation of Ca(2+)-induced Ca(2+) release by ubiquitin protein ligase E3 component n-recognin UBR3 and 6 in cardiac myocytes

Ca(2+)-induced Ca(2+) release (CICR) from sarcoplasmic reticulum is a finely tuned process responsible for cardiac excitation and contraction. The ubiquitin–proteasome system (UPS) as a major degradative system plays a crucial role in the maintenance of Ca(2+) homeostasis. The E3 component N-recogni...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiu-E, Liu, Bei, Zhao, Chun-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757829/
https://www.ncbi.nlm.nih.gov/pubmed/32988261
http://dx.doi.org/10.1080/19336950.2020.1824957
Descripción
Sumario:Ca(2+)-induced Ca(2+) release (CICR) from sarcoplasmic reticulum is a finely tuned process responsible for cardiac excitation and contraction. The ubiquitin–proteasome system (UPS) as a major degradative system plays a crucial role in the maintenance of Ca(2+) homeostasis. The E3 component N-recognin (UBR) subfamily is a part of the UPS; however, the role of UBR in regulating cardiac CICR is unknown. In the present study, we found that among the UBR family, single knockdown of UBR3 or UBR6 significantly elevated the amplitude of sarcoplasmic reticulum Ca(2+) release without affecting Ca(2+) transient decay time in neonatal rat ventricular myocytes. The protein expression of alpha 1 C subunit of L-type voltage-dependent Ca(2+) channel (Ca(v)1.2) was increased after UBR3/6 knockdown, whereas the protein levels of RyR2, SERCA2a, and PLB remained unchanged. In line with the increase in Ca(v)1.2 proteins, the UBR3/6 knockdown enhanced the current of Ca(v)1.2 channels. Furthermore, the increase in Ca(v)1.2 proteins caused by UBR3/6 reduction was not counteracted by a protein biosynthesis inhibitor, cycloheximide, suggesting a degradative regulation of UBR3/6 on Ca(v)1.2 channels. Our results indicate that UBR3/6 modulates cardiac CICR via targeting Ca(v)1.2 protein degradation.